Sohyun Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sohyun Park has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Byunghee Kang
Department of Life Sciences, Pohang University of Science and Technology (POSTECH) , Pohang 37673
1 shared publication - Chan Johng Kim
Department of Biochemistry, University of Washington, Seattle, WA, USA
1 shared publication - Hyeonji Lee
Pohang University of Science and Technology (POSTECH)
1 shared publication - Hyo-Min Kim
College of Pharmacy, Ewha Womans University, Seoul, Republic of Korea
1 shared publication - Hyorim Park
Department of Life Sciences, Pohang University of Science and Technology (POSTECH) , Pohang 37673, Republic of Korea
1 shared publication - Mi-Na Kweon
Mucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 9 May 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 51 (12) , 6143-6155
Forkhead box protein D2 suppresses colorectal cancer by reprogramming enhancer interactions
Somatic stem cells contribute to normal tissue homeostasis, and their epigenomic features play an important role in regulating tissue identities or developing disease states. Enhancers are one of the key players controlling chromatin context-specific gene expression in a spatial and temporal manner while maintaining tissue homeostasis, and their dysregulation leads to tumorigenesis. Here, epigenomic and transcriptomic analyses reveal that forkhead box protein D2 (FOXD2) is a hub for the gene regulatory network exclusive to large intestinal stem cells, and its overexpression plays a significant role in colon cancer regression. FOXD2 is positioned at the closed chromatin and facilitates mixed-lineage leukemia protein-4 (MLL4/KMT2D) binding to deposit H3K4 monomethylation. De novo FOXD2-mediated chromatin interactions rewire the regulation of p53-responsive genes and induction of apoptosis. Taken together, our findings illustrate the novel mechanistic details of FOXD2 in suppressing colorectal cancer growth and suggest its function as a chromatin-tuning factor and a potential therapeutic target for colorectal cancer.
- 9 May 2023
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 51 (12) , 6143-6155
Open AccessForkhead box protein D2 suppresses colorectal cancer by reprogramming enhancer interactions
Somatic stem cells contribute to normal tissue homeostasis, and their epigenomic features play an important role in regulating tissue identities or developing disease states. Enhancers are one of the key players controlling chromatin context-specific gene expression in a spatial and temporal manner while maintaining tissue homeostasis, and their dysregulation leads to tumorigenesis. Here, epigenomic and transcriptomic analyses reveal that forkhead box protein D2 (FOXD2) is a hub for the gene regulatory network exclusive to large intestinal stem cells, and its overexpression plays a significant role in colon cancer regression. FOXD2 is positioned at the closed chromatin and facilitates mixed-lineage leukemia protein-4 (MLL4/KMT2D) binding to deposit H3K4 monomethylation. De novo FOXD2-mediated chromatin interactions rewire the regulation of p53-responsive genes and induction of apoptosis. Taken together, our findings illustrate the novel mechanistic details of FOXD2 in suppressing colorectal cancer growth and suggest its function as a chromatin-tuning factor and a potential therapeutic target for colorectal cancer.